https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 P2/N95 respirators & surgical masks to prevent SARS-CoV-2 infection: effectiveness & adverse effects https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49615 Wed 14 Jun 2023 18:25:34 AEST ]]> Assessing a temporary isolation room from an infection control perspective: A discussion paper https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42916 Wed 07 Sep 2022 10:15:26 AEST ]]> Risk of organism acquisition from prior room occupants: An updated systematic review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54492 Tue 27 Feb 2024 15:12:42 AEDT ]]> A systematic review of healthcare-associated infectious organisms in medical radiation science departments: preliminary findings https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48297 Tue 14 Mar 2023 12:28:45 AEDT ]]> Organisation and governance of infection prevention and control in Australian residential aged care facilities: a national survey https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42693 Thu 01 Sep 2022 09:27:28 AEST ]]> The use of clinical coding data for the surveillance of healthcare-associated urinary tract infections in Australia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29250 Sat 24 Mar 2018 07:36:46 AEDT ]]> Evaluating bio-burden of frequently touched surfaces using Adenosine Triphosphate bioluminescence (ATP): results from the Researching Effective Approaches to Cleaning in Hospitals (REACH) trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39038 Mon 29 Jan 2024 17:52:28 AEDT ]]> Measuring environmental contamination in critical care using dilute hydrogen peroxide (DHP) technology: an observational cross-over study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37705 2.5 cfu/cm2 to indicate hygiene failure. Results: There were low levels of microbial contamination in the unit for baseline; DHP; and no DHP phases: 2.2% (95% CI 0.7-5.4%) vs 7.7% (95% CI 4.3-13.0%) vs 6% (95% CI 3.2-10.4%) hygiene failures, respectively. Significant reduction in ACCs did not occur when the DHP was operating compared with baseline and control phases. Conclusion: Further work is needed to determine whether continuous DHP technology has a role in decontamination for healthcare settings.]]> Mon 22 Mar 2021 10:00:53 AEDT ]]>